Related references
Note: Only part of the references are listed.Impact of Mutations at Residue I223 of the Neuraminidase Protein on the Resistance Profile, Replication Level, and Virulence of the 2009 Pandemic Influenza Virus
Andres Pizzorno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Therapeutic Activity of Intramuscular Peramivir in Mice Infected with a Recombinant Influenza A/WSN/33 (H1N1) Virus Containing the H275Y Neuraminidase Mutation
Yacine Abed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses
Wai Lan Wu et al.
ANTIVIRAL RESEARCH (2012)
Peramivir for the treatment of influenza
Avinash K. Shetty et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir
Jennifer L. McKimm-Breschkin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A (H1N1)pdm09 Influenza in Australia
A. C. Hurt et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Presence of Oseltamivir-Resistant Pandemic A/H1N1 Minor Variants Before Drug Therapy With Subsequent Selection and Transmission
Elodie Ghedin et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
The H275Y Neuraminidase Mutation of the Pandemic A/H1N1 Influenza Virus Lengthens the Eclipse Phase and Reduces Viral Output of Infected Cells, Potentially Compromising Fitness in Ferrets
Lady Tatiana Pinilla et al.
JOURNAL OF VIROLOGY (2012)
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
Aeron C. Hurt et al.
LANCET INFECTIOUS DISEASES (2012)
Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses
Jack T. Nguyen et al.
PLOS ONE (2012)
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010-11
Aaron D. Storms et al.
EMERGING INFECTIOUS DISEASES (2012)
Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets
Marie-Eve Hamelin et al.
ANTIVIRAL THERAPY (2011)
Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza
Hideyuki Ikematsu et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors
Andres Pizzorno et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Community Transmission of Oseltamivir-Resistant A(H1N1)pdm09 Influenza
Aeron C. Hurt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Computational-Experimental Approach Identifies Mutations That Enhance Surface Expression of an Oseltamivir-Resistant Influenza Neuraminidase
Jesse D. Bloom et al.
PLOS ONE (2011)
Influenza Drug Resistance
Andres Pizzorno et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Role of Permissive Neuraminidase Mutations in Influenza A/Brisbane/59/2007-like (H1N1) Viruses
Yacine Abed et al.
PLOS PATHOGENS (2011)
Assessment of Pandemic and Seasonal Influenza A (H1N1) Virus Susceptibility to Neuraminidase Inhibitors in Three Enzyme Activity Inhibition Assays
Ha T. Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Intravenous Zanamivir for Patients with Pneumonitis due to Pandemic (H1N1) 2009 Influenza Virus
Georg Haerter et al.
CLINICAL INFECTIOUS DISEASES (2010)
Oseltamivir-Resistant Variants of the 2009 Pandemic H1N1 Influenza A Virus Are Not Attenuated in the Guinea Pig and Ferret Transmission Models
Christopher W. Seibert et al.
JOURNAL OF VIROLOGY (2010)
Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus.
Erhard van der Vries et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
Jesse D. Bloom et al.
SCIENCE (2010)
Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses
Maki Kiso et al.
PLOS PATHOGENS (2010)
Oseltamivir-Resistant Pandemic H1N1/2009 Influenza Virus Possesses Lower Transmissibility and Fitness in Ferrets
Susu Duan et al.
PLOS PATHOGENS (2010)
Oseltamivir-Resistant Pandemic A/H1N1 Virus Is as Virulent as Its Wild-Type Counterpart in Mice and Ferrets
Marie-Eve Hamelin et al.
PLOS PATHOGENS (2010)
Rare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs
Clyde Dapat et al.
EMERGING INFECTIOUS DISEASES (2010)
Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro
Jack T. Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2009)
Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Nila J. Dharan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
Aeron C. Hurt et al.
JOURNAL OF VIROLOGY (2009)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza
Debra Birnkrant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein
Gallen B. Triana-Baltzer et al.
PLOS ONE (2009)
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008
Tiffany G. Sheu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
Bo-Jian Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an Immunocompromised child
Mariana Baz et al.
CLINICAL INFECTIOUS DISEASES (2006)
Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors
VP Mishin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations
Y Abed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza
K Shiraishi et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
JAL Ives et al.
ANTIVIRAL RESEARCH (2002)
Oral oseltamivir treatment of influenza in children
RJ Whitley et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Share Paper
